Literature DB >> 21271254

[Worsening of vision with apparent changes of the posterior pole].

C Mayer1, E Glaser, R Khoramnia.   

Abstract

The choroidal osteoma is a typically unilateral, benign ossifying tumor of the choroid. It is mostly located in the juxtapapillary area and usually found in females in the second or third decade of life. Most patients are asymptomatic. However, some can present with blurred vision, metamorphopsia, and visual field defects. Ultrasonography can show a calcified choroidal plaque with a typical shadowing posterior to the lesion. Fluorescein angiography and optical coherence tomography should be used if choroidal neovascularization is suspected as a possible complication of the choroidal osteoma.

Entities:  

Mesh:

Year:  2011        PMID: 21271254     DOI: 10.1007/s00347-010-2319-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  5 in total

1.  Macular choroidal osteoma with progressive widespread outer-retinal dysfunction.

Authors:  Rustum Karanjia; Jeffrey G Gale; Martin W ten Hove
Journal:  Can J Ophthalmol       Date:  2010-04       Impact factor: 1.882

2.  [Idiopathic sclero-choroid calcification].

Authors:  N Ségur-Eltz; M Zehetmayer; W Hauff; M Georgopoulos; W Schima; H Freyler
Journal:  Klin Monbl Augenheilkd       Date:  1999-12       Impact factor: 0.700

3.  [Deterioration of vision in conjunction with retinal changes].

Authors:  T Ahrens; P Wreesmann
Journal:  Ophthalmologe       Date:  2009-06       Impact factor: 1.059

Review 4.  Choroidal osteoma.

Authors:  C L Shields; J A Shields; J J Augsburger
Journal:  Surv Ophthalmol       Date:  1988 Jul-Aug       Impact factor: 6.048

5.  Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.

Authors:  R Narayanan; V A Shah
Journal:  Eur J Ophthalmol       Date:  2008 May-Jun       Impact factor: 2.597

  5 in total
  1 in total

1.  [Choroidal osteoma].

Authors:  N Negraszus
Journal:  Ophthalmologe       Date:  2012-06       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.